President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals sweeping changes to the drug and treatment pricing agency within the ...

The Biden executive order paved the way for the Center for Medicare and Medicaid Innovation, or CMMI, to create three drug pricing models intended to lower the costs of gene and cell therapies for ...